SARS-CoV-2-IN-109

MedChem Express

SARS-CoV-2-IN-109

5

Research Use Only

C34H26N2O2

494.58

SARS-CoV-2-IN-109 (compound 50) is an inhibitor targeting SARS-CoV with in vivo anti-infection activity. SARS-CoV-2-IN-109 targets the interaction between the SARS-CoV-2 Spike receptor-binding domain (RBD) and the human receptor angiotensin-converting enzyme 2 (ACE2) (EC50=26.5 microM), blocking the entry of SARS-CoV-2 into VeroE6 cells (EC50=17.0 microM). The CC50 of SARS-CoV-2-IN-109 for VeroE6 cells is >100 microM[1].

[H][C@@]12C3=CC=CC=C3C=CN1[C@](C(C4=CC=CC=C4)=O)([H])[C@]5([H])C6=C(C=CC=C6)C=CN5[C@@]2([H])C(C7=CC=CC=C7)=O

12352200